Form 4 holding
Chief Financial Officer
RxSight, Inc.
- Security class
- Common Stock
- Shares / value
- 12,373
- Estimated value
- $94,158
- Report date
- 28 Feb 2026
- Price
- $7.61
- Ownership
- Direct
Mark Wilterding
Insider Reports History
- Location
- Aliso Viejo, CA
- Owner filing signature
- /s/ Jim Schindler, as Attorney-in-Fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 identity field
SEC source record
1 source field
Source evidence
1 source field
Reported holdings for Mark Wilterding
Form 4 holding
Chief Financial Officer
RxSight, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 258,770
- Estimated value
- Report date
- 12 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
RxSight, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 143,087
- Estimated value
- Report date
- 28 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Mark Wilterding
4
RXST
RxSight, Inc.
- Report period
- 28 Feb 2026
- Transactions
- 3
- Transaction value
- -$61,397
- Accepted by SEC
- 03 Mar 2026, 20:24
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
RXST
RxSight, Inc.
- Report period
- 12 Jan 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 30 Jan 2026, 16:14
- Role
- Chief Financial Officer
- Next action
- Open filing details
3
RXST
RxSight, Inc.
- Report period
- 11 Jan 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 30 Jan 2026, 16:14
- Role
- Chief Financial Officer
- Next action
- Open filing details